| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ozioma S. Chioma | Q88402674 |
| P2093 | author name string | Wonder P Drake | |
| P2860 | cites work | Molecular Insight into Gut Microbiota and Rheumatoid Arthritis | Q26752055 |
| Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs | Q26779192 | ||
| Up-to-Date Information on Rheumatoid Arthritis-Associated Interstitial Lung Disease | Q26825098 | ||
| HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis. | Q54651325 | ||
| Idiopathic pulmonary fibrosis | Q56764887 | ||
| Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice | Q57217570 | ||
| Interstitial lung disease in dermatomyositis: clinicopathological study | Q68819450 | ||
| The pathogenesis of trehalose dimycolate-induced interstitial pneumonitis. III. Evidence for a role for T lymphocytes | Q71005969 | ||
| Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction | Q73526654 | ||
| Elevation of antibodies to cytomegalovirus and other herpes viruses in pulmonary fibrosis | Q73734162 | ||
| Experimental pulmonary fibrosis induced by Paracoccidioides brasiliensis conidia: measurement of local host responses | Q74515825 | ||
| Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis | Q80175360 | ||
| Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study | Q84053678 | ||
| Combined itraconazole-pentoxifylline treatment promptly reduces lung fibrosis induced by chronic pulmonary paracoccidioidomycosis in mice | Q85048061 | ||
| Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature | Q27004290 | ||
| Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis | Q27469497 | ||
| Human cytomegalovirus infection activates and regulates the unfolded protein response | Q27469611 | ||
| Muc5b is required for airway defence | Q28589969 | ||
| Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis | Q28943334 | ||
| Mechanisms of fibrosis: therapeutic translation for fibrotic disease | Q29620307 | ||
| Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study | Q30384494 | ||
| Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases | Q33557157 | ||
| Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. | Q33605234 | ||
| Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection | Q33775924 | ||
| γ-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosis | Q34001662 | ||
| An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus | Q34065673 | ||
| Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases | Q34113496 | ||
| Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review | Q34230722 | ||
| Transforming growth factor-beta and fibrosis | Q34232534 | ||
| Anti-inflammatory effects of macrolides in lung disease | Q34271885 | ||
| ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis | Q34537989 | ||
| Herpes virus infection is associated with vascular remodeling and pulmonary hypertension in idiopathic pulmonary fibrosis | Q34611385 | ||
| Antibiotics as anti-inflammatory agents | Q34675559 | ||
| Intratracheal instillation of high dose adenoviral vectors is sufficient to induce lung injury and fibrosis in mice | Q34796316 | ||
| The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis | Q34986902 | ||
| Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis | Q35027515 | ||
| Ganciclovir antiviral therapy in advanced idiopathic pulmonary fibrosis: an open pilot study | Q35028793 | ||
| Viral infection in acute exacerbation of idiopathic pulmonary fibrosis | Q35107245 | ||
| Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis | Q35533486 | ||
| Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland | Q35535058 | ||
| Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis | Q35535282 | ||
| Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease | Q35609105 | ||
| Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis | Q35683001 | ||
| Incorporating genetics into the identification and treatment of Idiopathic Pulmonary Fibrosis | Q35786160 | ||
| Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-gamma receptor-deficient mice | Q35855163 | ||
| A common MUC5B promoter polymorphism and pulmonary fibrosis. | Q36048530 | ||
| Pulmonary fibrosis induced by γ-herpesvirus in aged mice is associated with increased fibroblast responsiveness to transforming growth factor-β. | Q36080171 | ||
| Depletion of Neutrophils Promotes the Resolution of Pulmonary Inflammation and Fibrosis in Mice Infected with Paracoccidioides brasiliensis | Q36149864 | ||
| Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. | Q36514065 | ||
| Idiopathic pulmonary fibrosis: is it a familial disease? | Q36574387 | ||
| Torque teno virus (TTV): current status | Q36674068 | ||
| Adenovirus infections and lung disease | Q36796501 | ||
| Pulmonary paracoccidioidomycosis | Q37118858 | ||
| Pulmonary immune responses induced in BALB/c mice by Paracoccidioides brasiliensis conidia | Q37263042 | ||
| Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis | Q37362701 | ||
| Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes | Q37376136 | ||
| Immuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin. | Q37722509 | ||
| A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes | Q37764937 | ||
| Do infections facilitate the emergence of systemic sclerosis? | Q37791690 | ||
| Pathogenesis and host control of gammaherpesviruses: lessons from the mouse | Q37827143 | ||
| The role of infection in the pathogenesis of idiopathic pulmonary fibrosis. | Q38133505 | ||
| Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies | Q38448525 | ||
| From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis. | Q38845119 | ||
| Mediastinal fibrosis complicating histoplasmosis | Q39519305 | ||
| Pulmonary manifestations of nontuberculous Mycobacterium | Q40443736 | ||
| Pulmonary illness associated with exposure to Mycobacterium-avium complex in hot tub water. Hypersensitivity pneumonitis or infection? | Q40654457 | ||
| Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management | Q40859210 | ||
| Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin. | Q40949850 | ||
| Serum torque teno virus DNA titer in idiopathic pulmonary fibrosis patients with acute respiratory worsening | Q41253772 | ||
| Chronic exposure to staphylococcal superantigen elicits a systemic inflammatory disease mimicking lupus | Q42534500 | ||
| Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model | Q42875432 | ||
| Idiopathic Pulmonary Fibrosis and High Prevalence of Serum Antibodies to Hepatitis C Virus | Q42981496 | ||
| Idiopathic pulmonary fibrosis and hepatitis C virus infection | Q43035239 | ||
| Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection | Q43043836 | ||
| A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis | Q43662412 | ||
| Stage IV sarcoidosis: comparison of survival with the general population and causes of death. | Q43800062 | ||
| Infection of TT virus in patients with idiopathic pulmonary fibrosis | Q43846172 | ||
| Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis. | Q43865383 | ||
| Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial | Q44137651 | ||
| Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice | Q44227383 | ||
| Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis. | Q44233204 | ||
| The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis | Q44413322 | ||
| Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients | Q45094470 | ||
| Epstein-Barr virus DNA in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis | Q45394865 | ||
| The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis | Q45750246 | ||
| Familial idiopathic pulmonary fibrosis: clinical features and outcome | Q47782490 | ||
| MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility. | Q48014469 | ||
| Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. | Q50853560 | ||
| Aspergilloma coexisting with idiopathic pulmonary fibrosis: a rare occurrence. | Q51231492 | ||
| Chronic fibrosing pulmonary aspergillosis: a cause of 'destroyed lung' syndrome. | Q52971199 | ||
| Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. | Q53486707 | ||
| Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. | Q53580610 | ||
| A novel screening method detects herpesviral DNA in the idiopathic pulmonary fibrosis lung. | Q54391619 | ||
| Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort. | Q54418482 | ||
| P433 | issue | 2 | |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P304 | page(s) | 219-227 | |
| P577 | publication date | 2017-06-23 | |
| P1433 | published in | Yale Journal of Biology and Medicine | Q15709982 |
| P1476 | title | Role of Microbial Agents in Pulmonary Fibrosis | |
| P478 | volume | 90 |
Search more.